← Back to EMF Signal Current Medical Science
Research Therapeutic

Review examines pulsed electromagnetic fields as a possible addition to cancer treatment

October 11, 2026 (EMFS)
Oct 8, 2026 (original)
Source: Current Medical Science
Source category: Therapeutic
AI use

A review in Current Medical Science examines pulsed electromagnetic fields, a noninvasive therapy already used for bone and musculoskeletal conditions, as a possible tool against cancer. Its authors, a group at a medical institution in Wuhan, synthesize two decades of mostly laboratory and animal evidence on how the fields appear to act on tumors, including triggering programmed cell death, interfering with blood-vessel growth, altering cell metabolism and increasing the sensitivity of tumors to radiotherapy and chemotherapy.

The review reports that in preclinical models the fields can slow growth and kill malignant cells while doing comparatively little harm to normal cells, across breast cancer, glioma, liver cancer, melanoma and other types. The authors are careful to say that human studies remain preliminary, that the main evidence so far is a good safety record, and that any routine clinical use would first require large, well-designed randomized trials to set treatment protocols and define where the therapy fits in cancer care.

🔬 This research is covered in EMF Signal's section on therapeutic EMF applications. It investigates controlled use of electromagnetic fields as potential treatment, not environmental exposure.

Quotes

"Pulsed electromagnetic fields (PEMFs) are a noninvasive, safe, and well-tolerated physical therapy modality with established applications in musculoskeletal disorders."

— Zeng et al.

"Preclinical studies suggest that PEMFs can selectively suppress proliferation and promote cell death in malignant cells while exerting comparatively limited cytotoxicity in normal cells."

— Zeng et al.

"Evidence has been reported in models of breast cancer, glioma, hepatocellular carcinoma, melanoma, and other malignancies."

— Zeng et al.

"Although clinical investigations remain preliminary, studies conducted over the past two decades support a favorable safety profile and suggest potential therapeutic efficacy, particularly in combination with chemotherapy, radiotherapy, or immunotherapy."

— Zeng et al.

"Ultimately, the integration of PEMFs into routine oncology practice will require well-designed, large-scale randomized controlled trials to standardize treatment protocols, define clinical indications, and establish their role in multimodal cancer care."

— Zeng et al.

Related coverage

Location

📍 China

Map: China

Source

Beyond Tumor Treating Fields: Multimodal Antitumor Action and the Clinical Potential of Pulsed Electromagnetic Fields pubmed.ncbi.nlm.nih.gov

📄 Underlying Research

Beyond Tumor Treating Fields: Multimodal Antitumor Action and the Clinical Potential of Pulsed Electromagnetic Fields

Zeng QW, Liu MJ, Yi LS, Wu S, Zhu PP, Hu HZ (2026) Current Medical Science Journal Level 0ⓘ

🔗 DOI 📚 PubMed 📰 Full Article

More on this topic